Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment.

Podobne zapisy

• Pharmacokinetics of Single-Dose Oral Stavudine in Subjects with Renal Impairment and in Subjects Requiring Hemodialysis
  od: Grasela, Dennis M., i wsp.
  Wydane: (2000)
• Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
  od: Kurata, Akifumi, i wsp.
  Wydane: (2019)
• Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
  od: Innes, Steve, i wsp.
  Wydane: (2018)
• Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
  od: Marcinak, John, i wsp.
  Wydane: (2018)
• An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline
  od: Kovacs, Steven J., i wsp.
  Wydane: (2020)